Regulatory
Sep 16, 2026 · 1 min read · 37,975 views
FDA says initial rejections of new drugs have declined
S
Sophia Reyes
Editorial · Sep 16, 2026
An FDA report pushes back on claims it's rejecting more drugs, showing first-cycle rejection rates fell from 47% in 2008 to about 27% in 2024
← Previous
How past Endpoints 11 winners fared as the biotech industry rebounded
Next →
Seeking a fresh start, Novo drops the 'Nordisk'
